Prostate Cancer

Study to compare prostate cancer progression (pathological or therapeutic progression) between patients treated with enzalutamide versus patients undergoing active surveillance.

Prostate Cancer

1 year study to evaluate and compare the overall safety and tolerability of degarelix with leuprolide.

Prostate Cancer

Study to assess the efficacy of rucaparib in patients with HRD.

Prostate Cancer

4-year study to assess the efficacy of rucaparib versus physician’s choice of treatment for BRCA or ATM.

Prostate Cancer

Study to evaluate the ability of relugolix to achieve and maintain serum testosterone suppression to castrate levels in men with androgen-sensitive advanced prostate cancer.

Prostate Cancer

Study to test adjuvant therapy with ProstAtak for newly diagnosed prostate cancer.

Prostate Cancer

Study to determine if the use of GMCI will demonstrate a more favorable clinical outcome compared to a placebo-control group in prostate cancer patients undergoing active surveillance.

Start typing and press Enter to search